Physician profile
Jenny Tam
NPI 1184990343
$5,819.92
in general payments reported to CMS, 2019-2025
16 companies · $5,168 in 2025
The $5,168 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $263 · 2021: $80.16 · 2022: $207 · 2025: $5,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,568 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,567.54 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,567.54 | 2025 | |
| Ethicon Endo-Surgery INC. | $600.00 | 2025 | |
| Medtronic, INC. | $194.04 | 2022 | |
| Abbvie INC. | $192.57 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.65 | 2020 | |
| Covidien LP | $30.83 | 2020 | |
| Vertical Pharmaceuticals, LLC | $30.49 | 2020 | |
| Dysis Medical, INC. | $25.20 | 2019 | |
| Coopersurgical, INC. | $24.82 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $19.16 | 2021 | |
| Exeltis, USA INC. | $18.71 | 2019 | |
| Amag Pharmaceuticals, INC. | $17.94 | 2019 | |
| Hologic Sales and Service, LLC | $14.70 | 2019 | |
| Allergan, INC. | $13.50 | 2019 | |
| Ethicon US, LLC | $13.00 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Tam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.